ASND Ascendis Pharma
1,271
$128.22
$1.22
(0.94%)
| Watchers | 1,271 |
| 52-Wk Low | $83.75 |
| 52-Wk High | $161.00 |
| Market Cap | $7.33B |
| Volume | 70,264.00 |
| 52-Wk High | $161.00 |
| 52-Wk Low | $83.75 |
Ascendis Pharma A/S (NASDAQ:ASND) Given New $167.00 Price Target at JPMorgan Chase & Co.Zolmax • about 2 months ago
Ascendis Pharma A/S (NASDAQ:ASND - Free Report) had its target price boosted by JPMorgan Chase & Co. from $165.00 to $167.00 in a research note issued to investors on Tuesday morning, Benzinga...
Share to Feed
Cantor Fitzgerald reiterated their overweight rating on shares of Ascendis Pharma A/S (NASDAQ:ASND - Free Report) in a report published on Monday morning, Benzinga reports. Cantor Fitzgerald...
This is a Bullish indicator signaling ASND's price could rise from here. Traders may explore going long the stock or buying call options...
This is a signal that ASND's price trend could be reversing, and it may be an opportunity to sell the stock or take a defensive position...
Values First Advisors Inc. reduced its stake in Ascendis Pharma A/S (NASDAQ:ASND Free Report) by 23.4% in the fourth quarter, according to its most recent filing with the Securities and...
This is a signal that ASND's price trend could be reversing, and it may be an opportunity to buy the stock or explore call options...
Legato Capital Management LLC purchased a new stake in Ascendis Pharma A/S (NASDAQ:ASND Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities...
Shares of Ascendis Pharma A/S (NASDAQ:ASND Get Free Report) have been assigned an average rating of Moderate Buy from the ten analysts that are covering the firm, MarketBeat...
Shares of Ascendis Pharma A/S (NASDAQ:ASND Get Free Report) have been assigned an average rating of Moderate Buy from the ten analysts that are covering the firm, MarketBeat...
This is a signal that ASND's price trend could be reversing, and it may be an opportunity to buy the stock or explore call options...